IBSP通过BMP-SMAD信号通路促进乳腺癌骨转移和扩散
Wei Ding1,2, Di Lv1,2, Mengshen Wang1,2
1Department of General Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Cancer reports (Hoboken, N.J.)
|August 9, 2024
概括
综合素结合性蛋白 (IBSP) 通过通过BMP-SMAD4通路增强细胞迁移和入侵,促进乳腺癌的进展. 准IBSP为乳腺癌治疗提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 综合素结合性蛋白 (IBSP) 与各种癌症有关,但其在乳腺癌中的作用尚不清楚.
- 研究IBSP在乳腺癌进展中的机制对于确定治疗点至关重要.
研究的目的:
- 阐明IBSP在乳腺癌进展中的作用及其预后意义.
- 了解潜在的机制,包括BMP-SMAD信号通路.
- 探索IBSP作为一个潜在的治疗目标.
主要方法:
- 评估了IBSP过度表达和干扰对乳腺癌细胞迁移和入侵的影响.
- 分析了差异表达的基因和丰富的信号通路.
- 利用双 luciferase 记者测试来研究转录因子与 IBSP 促进体结合.
主要成果:
- IBSP过度表达增加了乳腺癌细胞的迁移和入侵; IBSP干扰减少了这些行为.
- BMP-SMAD信号通路在差异表达基因中显著丰富.
- 证实SMAD4可以绑定IBSP促销者,IBSP作为SMAD4的下游目标.
结论:
- IBSP通过BMP-SMAD4信号通路显著促进乳腺癌的进展.
- 针对IBSP是一个有前途的乳腺癌治疗策略.
- 对IBSP抑制剂的进一步研究可能会导致改善治疗结果.
相关概念视频
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


